Invaio Achieves First Registration for Citrus Greening Solution Featuring Trecise™ Technology

portfolio company news

Aug 29

Written By MacDougall Creative

MacDougall Creative https://www.macbiocom.com

Inozyme Pharma Announces Positive Interim Data from Ongoing Phase 1/2 Trials of INZ-701 in Adults with ENPP1 Deficiency and ABCC6 Deficiency (PXE)

MindMed Secures $50.0 Million Credit Facility with K2 HealthVentures